Human Chorionic Gonadotropin (hCG), β-Subunit, Qualitative

The β-hCG test detects a hormone called human chorionic gonadotropin in your blood or urine. This hormone is most commonly produced during pregnancy, starting very shortly after a fertilized egg implants in the uterus. A positive result usually means pregnancy is present, but your healthcare provider will consider your full clinical picture, as certain rare tumors can also produce this hormone. A negative result generally means the hormone is not detectable, which in most cases means pregnancy is not present, though very early pregnancies may occasionally test negative. Always discuss your results with your healthcare provider for proper interpretation.

When elevated: A positive (elevated) qualitative β-hCG result indicates the presence of hCG above the assay threshold, most commonly associated with intrauterine pregnancy, ectopic pregnancy, gestational trophoblastic disease (molar pregnancy, choriocarcinoma), or hCG-secreting germ cell tumors. In appropriate clinical context, it may also reflect recent pregnancy loss or exogenous hCG administration. When low: A negative qualitative β-hCG result indicates hCG is undetectable or below the assay threshold, effectively ruling out pregnancy in most clinical scenarios when tested appropriately. However, a negative result very early post-implantation does not definitively exclude pregnancy, and repeat testing may be warranted if clinical suspicion remains high.

β-hCG is not directly relevant to athletic performance, training load, or recovery monitoring in non-pregnant athletes. For female athletes of reproductive age, a qualitative β-hCG test is primarily a screening tool for pregnancy—important for medical clearance decisions, medication safety, and training modification, but not a performance or health-tracking biomarker.